Jazz Pharmaceuticals plc (JAZZ) stock
JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30119% above fair value
$241.55+1.18 (+0.49%)
Close on Nov 13, 2026Market cap $15.68BP/E 78.7Yield –
Jazz Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Jazz Pharmaceuticals's enterprise value was $18.16B on Nov 11, 2026, against $14.86B a year earlier. Over the last 5 years it ranged from $10.28B to $18.32B, with a median of $13.61B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $18.16B | +25.6% |
| 2025 | Dec 31, 2025 | $14.46B | +20.0% |
| 2024 | Dec 31, 2024 | $12.05B | -6.9% |
| 2023 | Dec 29, 2023 | $12.95B | -12.9% |
| 2022 | Dec 30, 2022 | $14.87B | +13.2% |
| 2021 | Dec 31, 2021 | $13.13B | +23.4% |
| 2020 | Dec 31, 2020 | $10.64B | +11.8% |
| 2019 | Dec 31, 2019 | $9.52B | +9.3% |
| 2018 | Dec 31, 2018 | $8.71B | -9.1% |
| 2017 | Dec 29, 2017 | $9.58B | +11.2% |
| 2016 | Dec 30, 2016 | $8.61B | -9.1% |
| 2015 | Dec 31, 2015 | $9.47B | -12.3% |
| 2014 | Dec 31, 2014 | $10.81B | +39.6% |
| 2013 | Dec 31, 2013 | $7.74B | +135.0% |
| 2012 | Dec 31, 2012 | $3.29B | +98.3% |
| 2011 | Dec 30, 2011 | $1.66B | +188.8% |
| 2010 | Dec 31, 2010 | $575.16M | – |
See a number that looks wrong?